South Wales, Feb. 16 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "MOLLAI" on Jan. 27. The details about the trademark application no. UK00004330731 published in the journal no. 2026/007 (Feb. 13).
With Wiggin LLP as representative, Abcam Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 9 : Downloadable artificial intelligence software for searching, filtering, comparing, recommending and purchasing laboratory reagents, antibodies, proteins, assay kits and research consumables; downloadable artificial intelligence software for retrieving, indexing and correlating scientific publications, research data, institutions, funding sources and scientific authors in the field of protein and antibody research; downloadable artificial intelligence (AI) software and downloadable machine learning software for natural language processing, question answering, recommendation, and predictive analytics in the field of life sciences and biotechnology; downloadable chatbot software for assisting users with product selection, technical queries, target identification, and literature discovery in the field of life sciences and biotechnology; downloadable chatbot software for simulating conversations in relation to the field of life sciences and biotechnology.
Class 42 : Software as a service (SaaS) featuring artificial intelligence software for identifying protein targets, correlating scientific publications, analysing research trends and recommending antibodies, proteins and laboratory reagents; providing temporary use of non downloadable artificial intelligence software for natural language processing, data mining, target identification, literature analysis, publication correlation, and product recommendation in the field of life sciences and biotechnology; platform as a service (PaaS) featuring artificial intelligence computer software platforms for research discovery, scientific knowledge retrieval and personalised digital research experiences in the field of life sciences and biotechnology; artificial intelligence as a service (AIaaS) being a chatbot for simulated conversation and performing generative text AI tasks in the field of life sciences and biotechnology; academic research services; biological research, scientific research, clinical research and medical research; software as a service (SaaS) featuring artificial intelligence software for assisting users with product selection, technical queries, target identification, and literature discovery in the field of life sciences and biotechnology; software as a service (SaaS) featuring artificial intelligence software for natural language processing, question answering, recommendation, and predictive analytics in the field of life sciences and biotechnology; software as a service (SaaS) featuring artificial intelligence software for retrieving, indexing and correlating scientific publications, research data, institutions, funding sources and scientific authors in the field of protein and antibody research; software as a service (SaaS) featuring artificial intelligence software for searching, filtering, comparing, recommending and purchasing laboratory reagents, antibodies, proteins, assay kits and research consumables; artificial intelligence as a service (AIaaS) being a chatbot for searching, filtering, comparing, recommending and purchasing laboratory reagents, antibodies, proteins, assay kits and research consumables; artificial intelligence as a service (AIaaS) being a chatbot for assisting users with product selection, technical queries, target identification, and literature discovery in the field of life sciences and biotechnology; artificial intelligence as a service (AIaaS) being a chatbot for natural language processing, question answering, recommendation, and predictive analytics in the field of life sciences and biotechnology.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004330731
Disclaimer: Curated by HT Syndication.
